​

Dianthus Therapeutics Ownership | Who Owns Dianthus Therapeutics?

OverviewForecastRevenueFinancialsChart

Dianthus Therapeutics Ownership Summary

Dianthus Therapeutics is owned by 109.17% institutional investors, 7.86% insiders. Fmr is the largest institutional shareholder, holding 16.67% of DNTH shares.

DNTH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockDianthus Therapeutics109.17%7.86%-17.03%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr5.97M16.67%$234.94M
Vestal point capital, lp3.20M8.93%$59.62M
Ra capital management2.87M8.00%$53.41M
Fairmount funds management2.71M7.56%$50.43M
Bain capital life sciences investors2.48M6.93%$46.24M
Deep track capital, lp2.23M6.23%$41.60M
Octagon capital advisors lp2.06M6.02%$38.08M
Avidity partners management lp1.74M4.87%$32.47M
Vanguard group1.64M4.58%$64.62M
Tcg crossover management1.50M4.19%$27.98M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Octagon capital advisors lp2.06M7.37%$38.08M
Fairmount funds management2.71M6.53%$50.43M
Avidity partners management lp1.74M6.47%$32.47M
Bain capital life sciences investors2.48M5.79%$46.24M
Sio capital management577.75K5.75%$22.73M
Silverarc capital management674.97K3.58%$26.56M
Tcg crossover management1.50M3.20%$27.98M
Vestal point capital, lp3.20M3.14%$59.62M
Vr adviser1.00M1.40%$18.63M
Deep track capital, lp2.23M1.33%$41.60M

Top Buyers

HolderShares% AssetsChange
Vestal point capital, lp3.20M3.14%1.50M
Fmr5.97M0.01%1.43M
Baker bros. advisors lp789.76K0.14%789.76K
Silverarc capital management674.97K3.58%579.16K
Marshall wace, llp572.94K0.02%572.94K

Top Sellers

HolderShares% AssetsChange
Vr adviser1.00M1.40%-744.37K
Janus henderson group---683.62K
Rtw investments, lp---666.67K
Braidwell lp---375.36K
Great point partners---275.00K

New Positions

HolderShares% AssetsChangeValue
Baker bros. advisors lp789.76K0.14%789.76K$14.71M
Marshall wace, llp572.94K0.02%572.94K$22.55M
Franklin resources450.31K0.00%450.31K$17.72M
Affinity asset advisors262.10K0.90%262.10K$10.31M
Patient square capital lp125.00K1.32%125.00K$4.92M

Sold Out

HolderChange
Creative financial designs inc /adv-10.00
Corecap advisors-11.00
Td private client wealth-17.00
Lindbrook capital-21.00
Srs capital advisors-32.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251041.96%39,106,7373.69%1090.90%48-3934.48%
Mar 31, 202512-87.23%14,988,897-56.30%430.44%5-90.74%3-86.36%
Dec 31, 2024964.35%35,129,79412.00%1021.22%55-2315.00%
Sep 30, 20249224.32%31,364,8085.60%911.22%5517.02%2025.00%
Jun 30, 202474-2.63%29,702,50213.90%860.84%47-25.40%16100.00%

Recent Insider Transactions

DateNameRoleActivityValue
Sep 09, 2025Savitz Ryan CFO & CBOSell$700.00K
Sep 29, 2023Fairmount Funds Management LLC Buy$336.25K
Sep 26, 2023Fairmount Funds Management LLC Buy$394.50K
Sep 19, 2023Fairmount Funds Management LLC Buy$396.00K
Sep 13, 2023Fairmount Funds Management LLC Buy$110.16K

Insider Transactions Trends

DateBuySell
2025 Q3-1
2025 Q2--
2025 Q1--
2024 Q3--
2024 Q2--

DNTH Ownership FAQ

Who Owns Dianthus Therapeutics?

Dianthus Therapeutics shareholders are primarily institutional investors at 109.17%, followed by 7.86% insiders and -17.03% retail investors. The average institutional ownership in Dianthus Therapeutics's industry, Biotech Stocks , is 295.31%, which Dianthus Therapeutics falls below.

Who owns the most shares of Dianthus Therapeutics?

Dianthus Therapeutics’s largest shareholders are Fmr (5.97M shares, 16.67%), Vestal point capital, lp (3.2M shares, 8.93%), and Ra capital management (2.87M shares, 8.00%). Together, they hold 33.60% of Dianthus Therapeutics’s total shares outstanding.

Does Blackrock own Dianthus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Dianthus Therapeutics.

Who is Dianthus Therapeutics’s biggest shareholder by percentage of total assets invested?

Octagon capital advisors lp is Dianthus Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.37% of its assets in 2.06M Dianthus Therapeutics shares, valued at 38.08M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools